[Betacap efficiency in elderly patients with coronary heart disease and essential hypertension].
OBJECTIVE
To assess the efficacy of long-acting propranolol in elderly patients with essential hypertension (EH) and coronary disease (CD).


METHODS
Sixteen patients (mean age 60 years) with EH and CD were examined using ECG and echoCG, chest rheoplethysmography, Holter ECG monitoring, and exercise test. Betacap was administered once a day in doses 40 or 80 mg at 10.00 or 13.00.


RESULTS
The drug exerted an antianginal and hypotensive effect. Energy expenditures of the myocardium decreased and exercise tolerance improved; the drug was more effective in patients with the hyperkinetic circulation and if taken at 10.00.


CONCLUSIONS
Betacap is an effective antianginal and hypotensive agent, recommended for therapy of elderly patients with EH and CD.
Zaslavskaia
R M
RM
Goncharov
L F
LF
Zholdin
B K
BK
Bisengalieva
G K
GK
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure; D002307:Cardiography, Impedance; D003692:Delayed-Action Preparations; D004452:Echocardiography; D015716:Electrocardiography, Ambulatory; D005080:Exercise Test; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D011433:Propranolol
Otsenka éffektivnositi betaképa u pozhilykh bol'nykh gipertonicheskoĭ bolezn'iu i ishemicheskoĭ bolezn'iu serdtsa.